.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Emma Fletcher

Sydney / AU

Garvan Institute of Medical Research

Speaker

01 June 2023
02.59 p.m. – 03.06 p.m. 5 Min. 2 Min.
LT 3-3
Bone-targeting bisphosphonates may boost immune responses to pulmonary infection by inhibiting the mevalonate pathway in alveolar macrophages
Metabolic regulation of innate immunity, Pattern recognition receptors and inflammasomes

Further involvements

01 June 2023
02.59 p.m. – 03.06 p.m. 5 Min. 2 Min.
LT 3-3
Bone-targeting bisphosphonates may boost immune responses to pulmonary infection by inhibiting the mevalonate pathway in alveolar macrophages
Metabolic regulation of innate immunity, Pattern recognition receptors and inflammasomes